TRPV4 and breast carcinoma: Furthermore, we exploited selective TRPV4 pharmacological inhibition and activation to define the role of TRPV4 in EMT induction and to determine if activation of a specific calcium-permeable ion channel is sufficient to induce EMT in breast cancer cells.